BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6802760)

  • 1. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
    Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
    Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.
    Anderson DC; Edwards MS; Baker CJ
    J Infect Dis; 1980 Mar; 141(3):370-81. PubMed ID: 6988524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.
    Yuste J; Sen A; Truedsson L; Jönsson G; Tay LS; Hyams C; Baxendale HE; Goldblatt F; Botto M; Brown JS
    Infect Immun; 2008 Aug; 76(8):3761-70. PubMed ID: 18541650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
    Braconier JH; Odeberg H; Sjöholm AG
    Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.
    Payne NR; Kim YK; Ferrieri P
    Infect Immun; 1987 May; 55(5):1243-51. PubMed ID: 3552996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls.
    Bortolussi R; Marrie TJ; Cunningham J; Schiffman G
    Infect Immun; 1981 Oct; 34(1):20-5. PubMed ID: 7028628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human complement by the pneumococcal toxin pneumolysin.
    Paton JC; Rowan-Kelly B; Ferrante A
    Infect Immun; 1984 Mar; 43(3):1085-7. PubMed ID: 6698602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Giebink GS; Verhoef J; Peterson PK; Quie PG
    Infect Immun; 1977 Nov; 18(2):291-7. PubMed ID: 21849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.
    Kaplan SL; Umstead CL; Mason EO; Anderson DC; Parke JC; Feigin RD
    J Clin Microbiol; 1981 Mar; 13(3):532-9. PubMed ID: 6972383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
    Bjornson AB; Lobel JS
    J Clin Invest; 1987 Feb; 79(2):388-98. PubMed ID: 3805275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.